214 related articles for article (PubMed ID: 26839979)
1. Effects of levosimendan on isolated human internal mammary artery and saphenous vein: concurrent use with conventional vasodilators.
Ertuna E; Turkseven S; Amanvermez D; Ayik F; Yagdi T; Yasa M
Fundam Clin Pharmacol; 2016 Jun; 30(3):226-34. PubMed ID: 26839979
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of levosimendan and papaverine on human internal mammary artery and saphenous vein.
Mirkhani H; Shafa M; Khazraei H
Cardiovasc Drugs Ther; 2009 Oct; 23(5):355-9. PubMed ID: 19826938
[TBL] [Abstract][Full Text] [Related]
3. A comparative study on in vitro and in vivo effects of topical vasodilators in human internal mammary, radial artery and great saphenous vein.
Ding R; Feng W; Li H; Wang L; Li D; Cheng Z; Guo J; Hu D
Eur J Cardiothorac Surg; 2008 Sep; 34(3):536-41. PubMed ID: 18632282
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: relevance to coronary bypass graft surgery.
He GW; Angus JA; Rosenfeldt FL
J Cardiovasc Pharmacol; 1988 Jul; 12(1):12-22. PubMed ID: 2459529
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of lidocaine hydrochloride on coronary artery bypass grafts.
Gur O; Ege T; Gurkan S; Ozkaramanli Gur D; Karadag H; Cakir H; Duran E
J Cardiovasc Surg (Torino); 2012 Oct; 53(5):665-9. PubMed ID: 22669098
[TBL] [Abstract][Full Text] [Related]
6. Papaverive abolishes endothelium-dependent dilatation of human internal mammary arteries in vitro.
Schyvens CG; Owe-Young RA; Spratt PM; Mundy JA; Farnsworth AE; Macdonald PS
Clin Exp Pharmacol Physiol; 1997; 24(3-4):223-8. PubMed ID: 9131289
[TBL] [Abstract][Full Text] [Related]
7. [Contractile properties of coronary artery bypass conduit--comparison between saphenous vein and internal mammary artery].
Koike R; Suma H; Kondoh K; Satoh H; Oku T; Sawada Y; Takeuchi A; Hirata K; Awano K; Yokoyama M
Kokyu To Junkan; 1990 Sep; 38(9):881-5. PubMed ID: 2236959
[TBL] [Abstract][Full Text] [Related]
8. Control of human vascular tone by prostanoids derived from perivascular adipose tissue.
Ozen G; Topal G; Gomez I; Ghorreshi A; Boukais K; Benyahia C; Kanyinda L; Longrois D; Teskin O; Uydes-Dogan BS; Norel X
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():13-7. PubMed ID: 23791663
[TBL] [Abstract][Full Text] [Related]
9. The vasodilatory effects of levosimendan on the human internal mammary artery.
Montes FR; Echeverri D; Buitrago L; Ramírez I; Giraldo JC; Maldonado JD; Umaña JP
Anesth Analg; 2006 Nov; 103(5):1094-8. PubMed ID: 17056938
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of coronary artery bypass graft materials: reduced contraction and ADMA levels in internal mammary artery versus saphenous vein.
Ozen G; Aljesri K; Turkyilmaz G; Turkyilmaz S; Kavala AA; Topal G; Norel X
J Cardiovasc Surg (Torino); 2022 Feb; 63(1):69-77. PubMed ID: 34472766
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison of relaxation and cGMP production in human coronary by-pass grafts in response to stimulation with natriuretic peptides and a nitric oxide donor.
Hammerer-Lercher A; Fersterer J; Holzmann S; Bonatti J; Ruttmann E; Hoefer D; Mair J; Puschendorf B
Clin Sci (Lond); 2006 Sep; 111(3):225-31. PubMed ID: 16709152
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
Sogo N; Campanella C; Webb DJ; Megson IL
Br J Pharmacol; 2000 Nov; 131(6):1236-44. PubMed ID: 11082133
[TBL] [Abstract][Full Text] [Related]
13. Diltiazem provides higher internal mammary artery flow than nitroglycerin during coronary artery bypass grafting surgery.
Tabel Y; Hepağuşlar H; Erdal C; Catalyürek H; Acikel U; Elar Z; Aslan O
Eur J Cardiothorac Surg; 2004 Apr; 25(4):553-9. PubMed ID: 15037271
[TBL] [Abstract][Full Text] [Related]
14. Preferential vasoconstriction to cysteinyl leukotrienes in the human saphenous vein compared with the internal mammary artery. Implications for graft performance.
Allen SP; Chester AH; Dashwood MR; Tadjkarimi S; Piper PJ; Yacoub MH
Circulation; 1994 Jul; 90(1):515-24. PubMed ID: 8026041
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in vascular reactivity of coronary artery bypass graft conduits.
Jaghoori A; Lamin V; Jacobczak R; Worthington M; Edwards J; Viana F; Stuklis R; Wilson DP; Beltrame JF
Heart Vessels; 2020 Mar; 35(3):422-431. PubMed ID: 31576420
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.
Liu MH; Floten SH; Yang Q; He GW
Br J Clin Pharmacol; 2001 Sep; 52(3):279-87. PubMed ID: 11560560
[TBL] [Abstract][Full Text] [Related]
17. The interaction between human urotensin II and vasodilator agents in human internal mammary artery with possible clinical implications.
Bai XY; Liu XC; Yang Q; Tang XD; He GW
Ann Thorac Surg; 2011 Aug; 92(2):610-6. PubMed ID: 21704284
[TBL] [Abstract][Full Text] [Related]
18. Effects of stretch or distention on phenylephrine-induced constriction of human coronary artery bypass grafts.
Wendling WW; Krasner LJ; Cooper SC; Chen D; Harakal C; Addonizio VP; Brister NW; Carlsson C
J Cardiothorac Vasc Anesth; 2001 Dec; 15(6):717-22. PubMed ID: 11748519
[TBL] [Abstract][Full Text] [Related]
19. The gender differences in the relaxation to levosimendan of human internal mammary artery.
Akar F; Manavbasi Y; Parlar AI; Ulus AT; Katircioglu SF
Cardiovasc Drugs Ther; 2007 Oct; 21(5):331-8. PubMed ID: 17703356
[TBL] [Abstract][Full Text] [Related]
20. The effects of botulinum toxin A and papaverine on human saphenous vein and internal mammary artery grafts: an
Duman I; Tanyeli Ö; Dereli Y; Oltulu P; Toy H; Sahin AS
Arch Med Sci; 2022; 18(6):1607-1616. PubMed ID: 36457963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
